Columbia researchers discover that DNA repair falters when cells can’t move damaged DNA to repair centers within the nucleus. The results could lead to better cancer treatments.
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.